1. E. van Cauter and S. Retetoff. Multifactorial control of the 24-hour secretory profiles of pituitary hormones.J. Endocrinol. Invest. 8:381–391 (1985).
2. W. A. Colburn and D. M. Gibson. Endogenous agonists and pharmacokinetic/pharmacodynamic modeling of baseline effects. In P. D. Kroboth, R. B. Smith, and R. P. Juhl (eds.),Pharmacokinetics and Pharmacodynamics: Vol. 2 Current Problems, Potential Solutions, Harvey Whitney, Cincinnati, OH, 1988, pp. 167–184.
3. N. H. G. Holford and L. B. Sheiner. Understanding the dose-effect relationship: Clinical application of pharmacokinetic-pharmacodynamic models.Clin. Pharmacokin. 6:429–453 (1981).
4. L. B. Sheiner, D. R. Stanski, S. Vozeh, R. D. Miller, and J. Ham. Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d-tubocurarine.Clin. Pharmacol. Ther. 25:358–371 (1979).
5. J. R. Keichel, J. L. Steimer, and A. Frydman. La modélisation pharmacocinétique et pharmacodynamique. In G. Strauch and A. Spriet (eds.),Pharmacologie Clinique: Actualités et Perspectives, Colloque INSERM, Paris, Vol. 156, 1987, pp. 91–118.